News

Dapagliflozin, an inhibitor of SGLT2, is being investigated to assess the safety and efficacy in improving glycemic control in adults with type 2 diabetes, for use as a

The new facility, which will more than double the current facility, is expected to get completed in 2012. The fill/finish suites will feature automated vial and syringe filling,

Fabrazyme (agalsidase beta) is used to treat patients with Fabry disease. Fabrazyme lowers the amount of a substance called globotriaosylceramide (GL-3), which builds up in cells lining the

The medical center will implement the EMPI solutions to increase data accuracy and minimize duplicate patient records. The 643-bed acute care facility can identify and resolve overlapping or

The trial demonstrated that IFX-1 is safe and well tolerated while displaying desirable PK and PD parameters and reached its anticipated endpoints. IFX-1 was designed to control the

Developed by APR and Labtec in partnership with Monosol RX, Setofilm is the first prescription product developed as an ‘orodispersible film’ form to be registered in Europe. Setofilm

Chlormethine gel also known as mechlorethamine gel in the US will relieve the signs and symptoms of CTCL. The initiative by EMA is intended to promote the development

Aptalis Pharma and Gilead have co-developed the oral powder formulation of Viread using the Aptalis Microcaps taste-masking technology. The Aptalis microencapsulation technology, known as Microcaps, employs versatile and

Azul Instant pill has been found to improve sexual stamina, endurance, strength and energy without any side effects. Hybrid Fuels CEO Ramiro Cadena said the new 100% natural